BeHappy Investments
Madrid, Spain3
2M
3
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Investments by industry
- Farming (1)
- Restaurants (1)
- Food and Beverage (1)
- Farmers Market (1)
- Shopping (1) Show 11 more
- Investments by region
- Spain (3)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 4
- Avg. valuation at time of investment
- 2M
- Group Appearance index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Velca | 29 Nov 2023 | Automotive, Electronic Design Automation (EDA), Electric Vehicle | Early Stage Venture | 4M | Madrid, Madrid, Spain |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Nuclidium | Oct 7, 2025 | Cancer Treatment, Diagnostics, Radiopharmaceuticals, Therapeutics | - | 84000000 EUR |  Basel |
| SNIPR BIOME | Aug 7, 2025 | CRISPR-Cas technology, CRISPR-medicine, Precision medicine | - | 35000000 EUR |  Copenhagen, |
| Hilo | May 5, 2025 | blood pressure intelligence platform, cuffless blood pressure monitoring, enterprise use cases | - | 42000000 USD | Neuchatel |
| HepaRegeniX | Apr 15, 2025 | Cancer Treatment, Drug Development, Liver Diseases, Liver Disease Therapies, Liver Regeneration, Regenerative Therapy | - | 21500000 EUR |  Tuebingen, Baden-Württemberg |
| Seamless Therapeutics | Mar 16, 2023 | Biotechnology, Gene Editing | Early stage | 12500000 USD | Dresden, Saxony |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.